Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Clinical trial NCT00424814 · COMPLETED
Trial details
- NCT number
- NCT00424814
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.